@article {3231,
	title = {When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.},
	journal = {Annals of internal medicine},
	volume = {154},
	year = {2011},
	month = {2011 Apr 19},
	pages = {509-15},
	abstract = {Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 {\texttimes} 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal CD4 cell count at which cART should be initiated remains a matter of debate.},
	keywords = {Acquired Immunodeficiency Syndrome, Anti-Retroviral Agents, Cause of Death, CD4 Lymphocyte Count, Developed Countries, Disease Progression, Drug Administration Schedule, Drug Therapy, Combination, HIV Infections, Humans, Observation, Proportional Hazards Models, Prospective Studies},
	issn = {1539-3704},
	doi = {10.7326/0003-4819-154-8-201104190-00001},
	author = {Cain, Lauren E and Logan, Roger and Robins, James M and Sterne, Jonathan A C and Sabin, Caroline and Bansi, Loveleen and Justice, Amy and Goulet, Joseph and van Sighem, Ard and de Wolf, Frank and Bucher, Heiner C and von Wyl, Viktor and Esteve, Anna and Casabona, Jordi and del Amo, Julia and Moreno, Santiago and Seng, Remonie and Meyer, Laurence and Perez-Hoyos, Santiago and Muga, Roberto and Lodi, Sara and Lanoy, Emilie and Costagliola, Dominique and Hernan, Miguel A}
}
